Atovaquone Glenmark

Atovaquone Glenmark is an oral medication used to treat and prevent certain parasitic infections. This antimalarial drug is manufactured by Glenmark Pharmaceuticals S.R.O. and is available for oral use.

Atovaquone is primarily used to treat and prevent malaria, a parasitic infection spread by mosquitoes. It works by stopping the growth of the parasite that causes malaria. This medication may also be used for other parasitic infections as determined by a healthcare provider. Atovaquone is often prescribed for individuals who are unable to take other antimalarial drugs due to allergies or resistance.

Common effects of Atovaquone may include nausea, vomiting, diarrhea, and stomach pain. Some users may experience headache, dizziness, or cough. These effects are generally mild and temporary. If any of these effects persist or worsen, it is important to consult a healthcare provider.

Atovaquone should be used with caution in individuals with liver or kidney problems. It is important to follow the prescribed dosage and complete the full course of treatment, even if symptoms improve. This medication should be stored at room temperature and kept out of reach of children. Always consult a healthcare provider before starting any new medication.

Atovaquone may interact with certain medications, including antacids, metoclopramide, and drugs that affect liver enzymes. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be avoided while taking Atovaquone, as it may increase the risk of side effects.